The efficacy of TACE combined sorafenib in advanced stages hepatocellullar carcinoma

BACKGROUND: The long-term survival in hepatocellullar carcinoma (HCC) patients after transarterial chemoembolization (TACE) remains dismal due to local and/or regional recurrence as well as distant metastasis. The efficacy of sorafenib in advanced HCC has been demonstrated and brought great hope. Re...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Qu, Xu-Dong, Chen, Cheng-Shi, Wang, Jian-Hua, Yan, Zhi-ping, Chen, Jie-min, Gong, Gao-quan, Liu, Qin-xin, Luo, Jian-jun, Liu, Lin-xiao, Liu, Rong, Qian, Sheng
Médium: Artigo
Jazyk:Inglês
Vydáno: BioMed Central 2012
Témata:
Research Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3411397/
https://ncbi.nlm.nih.gov/pubmed/22721173
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2407-12-263
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky